Similarly, while MyxASS1 and MyxASS1 FS displayed similar viral titers in tumors derived from ASS1 + B16F10 cells, MyxASS1 displayed a strong trend towards increased viral titers in tumors derived from two distinct ASS1 KO B16/F10 cell lines ( figure 6D ) as well as significantly increased titers in tumors derived from intrinsically ASS1-deficient A9F1 cells ( figure 6E ).
← all excerpts
Defects in intratumoral arginine metabolism attenuate the replication and therapeutic efficacy of oncolytic myxoma virus.
1
—
—